can i get a glp 1 if i'm not overweight GLP-1 Therapy Part 1: Setting Realistic Weight Loss Expectations – Sarah Hormachea GLP-1 If Not Overweight: Biomarker

Key Players in the GLP-1 Diabetes Treatment Drugs Market Eli Lilly Sanofi Novo Nordisk Hanmi Pharmaceutical Co Boehringer Ingelheim AstraZeneca Pfizer Inc Teva Pharmaceutical Industries Ltd GlaxoSmithKline (GSK) Ganli Pharmaceuticals Tonghua Dongbao Shanghai Renhui Biopharmaceuticals Co., Ltd

This is because theyre not meant to be a short-term fix but instead a chronic disease treatment for obesity

Salmeterol, on the other hand, while also an asthma medication permitted below a certain specified dose, is classified as a Section 4 Substance in the same way as higenamine, which is banned at all times

Here's what to watch for